Patent · US Active

Pyrazolo[5,1b]oxazole derivatives as CRF-1 receptor antagonists

US8163785B2 · kind B2 · utility

1Cited by

0References

11Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Nicholas James Devereux · Ash, GB
Jeffrey McKenna · Horsham, GB

Key dates

Filing date	Jan 31, 2011
Grant date	Apr 24, 2012
Priority date	—
Expiry date	Jan 31, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There are described 4-difluoromethoxyphenyl pyrazolo[5.1-b]oxazole derivatives of Formula I:which are useful as corticotropin releasing factor (CRF) receptor antagonists and as pharmaceuticals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.